Allergan’s Bold Patent Move Could Transform Pharma Landscape

Pharmaceutical giant Allergan struck a bold and unusual deal to protect its patents on a lucrative eye drug in September.
Allergan’s Bold Patent Move Could Transform Pharma Landscape
A technician works in a lab at Allergan's R&D and production site Sept. 27 in Pringy, France. Jean-Pierre Clatot/AFP/Getty Images
Fan Yu
Updated:

Pharmaceutical giant Allergan struck a bold and unusual deal to protect its patents on a lucrative eye drug in September.

If successful, the maneuver could have far-reaching ramifications and disrupt the established pharmaceutical industry order.

Fan Yu
Fan Yu
Author
Fan Yu is an expert in finance and economics and has contributed analyses on China's economy since 2015.
Related Topics